ABIN188570
antibody from antibodies-online
Targeting: TSPO
BZRP, DBI, IBP, MBR, mDRC, PBR, pk18, PKBS
Antibody data
- Antibody Data
- Antigen structure
- References [7]
- Comments [0]
- Validations
- Western blot [3]
- Immunohistochemistry [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- ABIN188570 - Provider product page
- Provider
- antibodies-online
- Product name
- anti-Peripheral-Type Benzodiazepine Receptor (TSPO) (C-Term) antibody
- Antibody type
- Polyclonal
- Description
- Immunogen affinity purified
- Reactivity
- Human
- Host
- Goat
- Epitope
- C-Term
- Vial size
- 0.1 mg
- Storage
- Store at -20°C. Avoid freeze-thaw cycles.
- Handling
- Avoid freeze-thaw cycles
Submitted references Preclinical TSPO Ligand PET to Visualize Human Glioma Xenotransplants: A Preliminary Study.
ERManI (Endoplasmic Reticulum Class I α-Mannosidase) Is Required for HIV-1 Envelope Glycoprotein Degradation via Endoplasmic Reticulum-associated Protein Degradation Pathway.
The mitochondrial translocator protein, TSPO, inhibits HIV-1 envelope glycoprotein biosynthesis via the endoplasmic reticulum-associated protein degradation pathway.
The 18-kDa translocator protein (TSPO) disrupts mammary epithelial morphogenesis and promotes breast cancer cell migration.
Peripheral benzodiazepine receptor regulates vascular endothelial activations via suppression of the voltage-dependent anion channel-1.
Translocator protein blockade reduces prostate tumor growth.
Translocator protein (18kDa): new nomenclature for the peripheral-type benzodiazepine receptor based on its structure and molecular function.
Buck JR, McKinley ET, Fu A, Abel TW, Thompson RC, Chambless L, Watchmaker JM, Harty JP, Cooper MK, Manning HC
PloS one 2015;10(10):e0141659
PloS one 2015;10(10):e0141659
ERManI (Endoplasmic Reticulum Class I α-Mannosidase) Is Required for HIV-1 Envelope Glycoprotein Degradation via Endoplasmic Reticulum-associated Protein Degradation Pathway.
Zhou T, Frabutt DA, Moremen KW, Zheng YH
The Journal of biological chemistry 2015 Sep 4;290(36):22184-92
The Journal of biological chemistry 2015 Sep 4;290(36):22184-92
The mitochondrial translocator protein, TSPO, inhibits HIV-1 envelope glycoprotein biosynthesis via the endoplasmic reticulum-associated protein degradation pathway.
Zhou T, Dang Y, Zheng YH
Journal of virology 2014 Mar;88(6):3474-84
Journal of virology 2014 Mar;88(6):3474-84
The 18-kDa translocator protein (TSPO) disrupts mammary epithelial morphogenesis and promotes breast cancer cell migration.
Wu X, Gallo KA
PloS one 2013;8(8):e71258
PloS one 2013;8(8):e71258
Peripheral benzodiazepine receptor regulates vascular endothelial activations via suppression of the voltage-dependent anion channel-1.
Joo HK, Lee YR, Lim SY, Lee EJ, Choi S, Cho EJ, Park MS, Ryoo S, Park JB, Jeon BH
FEBS letters 2012 May 7;586(9):1349-55
FEBS letters 2012 May 7;586(9):1349-55
Translocator protein blockade reduces prostate tumor growth.
Fafalios A, Akhavan A, Parwani AV, Bies RR, McHugh KJ, Pflug BR
Clinical cancer research : an official journal of the American Association for Cancer Research 2009 Oct 1;15(19):6177-84
Clinical cancer research : an official journal of the American Association for Cancer Research 2009 Oct 1;15(19):6177-84
Translocator protein (18kDa): new nomenclature for the peripheral-type benzodiazepine receptor based on its structure and molecular function.
Papadopoulos V, Baraldi M, Guilarte TR, Knudsen TB, Lacapère JJ, Lindemann P, Norenberg MD, Nutt D, Weizman A, Zhang MR, Gavish M
Trends in pharmacological sciences 2006 Aug;27(8):402-9
Trends in pharmacological sciences 2006 Aug;27(8):402-9
No comments: Submit comment
Supportive validation
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- WB
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- WB
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- WB
Supportive validation
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- IHC